Literature DB >> 26359089

Use of Fixed Combination Therapies to Improve Blood Pressure Control in the Clinical Management of Hypertension: A Key Opportunity.

Giuliano Tocci1,2, Agostino Virdis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26359089     DOI： 10.1007/s40292-015-0118-z

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN： 1120-9879


× No keyword cloud information.
  17 in total

1.  Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice.

Authors:  Giovanni Corrao; Andrea Parodi; Antonella Zambon; Franca Heiman; Alessandro Filippi; Claudio Cricelli; Luca Merlino; Giuseppe Mancia
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

4.  Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.

Authors:  Yuri A Karpov; Vladimir M Gorbunov; Alexander D Deev
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-09-09

5.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

6.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

7.  2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy.

Authors:  Massimo Volpe; Enrico Agabiti Rosei; Ettore Ambrosioni; Santina Cottone; Cesare Cuspidi; Claudio Borghi; Nicola De Luca; Francesco Fallo; Claudio Ferri; Alberto Morganti; Maria Lorenza Muiesan; Riccardo Sarzani; Leonardo Sechi; Agostino Virdis; Giuliano Tocci; Bruno Trimarco; Alessandro Filippi; Giuseppe Mancia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-28

8.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

9.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

10.  The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.

Authors:  C Raina Elley; Ajay K Gupta; Ruth Webster; Vanessa Selak; Min Jun; Anushka Patel; Anthony Rodgers; Simon Thom
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.